Authors:
STENDAL TL
KLEM W
TONNESEN HH
KJONNIKSEN I
Citation: Tl. Stendal et al., DRUG STABILITY AND PYRIDINE GENERATION IN CEFTAZIDIME INJECTION STORED IN AN ELASTOMERIC INFUSION DEVICE, American journal of health-system pharmacy, 55(7), 1998, pp. 683-685
Authors:
HJELSTUEN OK
TONNESEN HH
BREMER PO
VERBRUGGEN AM
Citation: Ok. Hjelstuen et al., 3'-TC-99M-LABELING AND BIODISTRIBUTION OF A CAPL ANTISENSE OLIGODEOXYNUCLEOTIDE, Nuclear medicine and biology, 25(7), 1998, pp. 651-657
Authors:
HJELSTUEN OK
MAELANDSMO GM
TONNESEN HH
BREMMER PO
VERBRUGGEN AM
Citation: Ok. Hjelstuen et al., HYBRIDIZATION OF TC-99(M)-LABELED OLIGODEOXYNUCLEOTIDE TO CAPL RNA, Nuclear medicine communications, 19(8), 1998, pp. 803-812
Authors:
KRISTENSEN S
NORD K
ORSTEEN AL
TONNESEN HH
Citation: S. Kristensen et al., PHOTOREACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS, XIV - INFLUENCE OF OXYGEN ON LIGHT-INDUCED REACTIONS OF PRIMAQUINE, Die Pharmazie, 53(2), 1998, pp. 98-103
Citation: S. Kristensen et al., PHOTOREACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .11. PRIMAQUINE AND METABOLITES AS RADICAL INDUCERS, European journal of pharmaceutical sciences, 5(3), 1997, pp. 139-146
Authors:
HJELSTUEN OK
TONNESEN HH
ROALD T
BREMER PO
CLEYNHENS B
VERBRUGGEN A
Citation: Ok. Hjelstuen et al., LABELING WITH TC-99M AND BIODISTRIBUTION OF A CAPL BREAST-CANCER ONCOGENE ANTISENSE OLIGODEOXYNUCLEOTIDE, The Journal of nuclear medicine, 38(5), 1997, pp. 322-322
Citation: K. Nord et al., PHOTOREACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .10. PHOTOREACTIVITYOF CHLOROQUINE IN AQUEOUS-SOLUTION, Die Pharmazie, 52(8), 1997, pp. 598-603
Authors:
GRINBERG LN
SHALEV O
TONNESEN HH
RACHMILEWITZ EA
Citation: Ln. Grinberg et al., STUDIES ON CURCUMIN AND CURCUMINOIDS .26. ANTIOXIDANT EFFECTS OF CURCUMIN ON THE RED-BLOOD-CELL MEMBRANE, International journal of pharmaceutics, 132(1-2), 1996, pp. 251-257
Authors:
KRISTENSEN S
WANG RH
TONNESEN HH
DILLON J
ROBERTS JE
Citation: S. Kristensen et al., PHOTOREACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .8. PHOTOSENSITIZED POLYMERIZATION OF LENS PROTEINS BY ANTIMALARIAL-DRUGS IN-VITRO, Photochemistry and photobiology, 61(2), 1995, pp. 124-130
Citation: Hh. Tonnesen et al., STUDIES ON CURCUMIN AND CURCUMINOIDS .24. CHARACTERIZATION OF THE SPECTROSCOPIC PROPERTIES OF THE NATURALLY-OCCURRING CURCUMINOIDS AND SELECTED DERIVATIVES, Die Pharmazie, 50(10), 1995, pp. 689-693
Authors:
KRISTENSEN S
ORSTEEN AL
SANDE SA
TONNESEN HH
Citation: S. Kristensen et al., PHOTOREACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .7. INTERACTION OF ANTIMALARIAL-DRUGS WITH MELANIN IN-VITRO AS PART OF PHOTOTOXICITY SCREENING, Journal of photochemistry and photobiology.B, Biology, 26(1), 1994, pp. 87-95
Authors:
KRISTENSEN S
ORSTEEN AL
SANDE SA
TONNESEN HH
Citation: S. Kristensen et al., PHOTOREACTIVITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .7. INTERACTION OF ANTIMALARIAL-DRUGS WITH MELANIN IN-VITRO AS PART OF PHOTOTOXICITY SCREENING, Journal of photochemistry and photobiology.B, Biology, 26(1), 1994, pp. 87-95
Citation: Hh. Tonnesen et al., STUDIES ON CURCUMIN AND CURCUMINOIDS .25. INHIBITION OF PRIMAQUINE-INDUCED LYSIS OF HUMAN RED-BLOOD-CELLS BY CURCUMIN, International journal of pharmaceutics, 110(2), 1994, pp. 161-167
Citation: K. Nord et al., PHOTOCHEMICAL STABILITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .9. CHARACTERIZATION OF THE SPECTROSCOPIC PROPERTIES OF THE 4-AMINOQUINOLINES, CHLOROQUINE AND HYDROXYCHLOROQUINE, AND OF SELECTED METABOLITES BY ABSORPTION, FLUORESCENCE AND PHOSPHORESCENCE MEASUREMENTS, Photochemistry and photobiology, 60(5), 1994, pp. 427-431
Citation: Hh. Tonnesen et al., STUDIES ON CURCUMIN AND CURCUMINOIDS .23. EFFECTS OF CURCUMIN ON LIPOSOMAL LIPID-PEROXIDATION, International journal of pharmaceutics, 90(3), 1993, pp. 221-228
Authors:
KRISTENSEN S
GRISLINGAAS AL
GREENHILL JV
SKJETNE T
KARLSEN J
TONNESEN HH
Citation: S. Kristensen et al., PHOTOCHEMICAL STABILITY OF BIOLOGICALLY-ACTIVE COMPOUNDS .5. PHOTOCHEMICAL DEGRADATION OF PRIMAQUINE IN AN AQUEOUS-MEDIUM, International journal of pharmaceutics, 100(1-3), 1993, pp. 15-23
Citation: Hh. Tonnesen, PHOTOCHEMICAL DEGRADATION OF COMPONENTS IN DRUG FORMULATIONS .1. AN APPROACH TO THE STANDARDIZATION OF DEGRADATION STUDIES, Die Pharmazie, 46(4), 1991, pp. 263-265